@Article{info:doi/10.2196/58124,
author="Kavanagh, Meaghan E
and Chiavaroli, Laura
and Quibrantar, Selina M
and Viscardi, Gabrielle
and Ramboanga, Kimberly
and Amlin, Natalie
and Paquette, Melanie
and Sahye-Pudaruth, Sandhya
and Patel, Darshna
and Grant, Shannan M
and Glenn, Andrea J
and Ayoub-Charette, Sabrina
and Zurbau, Andreea
and Josse, Robert G
and Malik, Vasanti S
and Kendall, Cyril W C
and Jenkins, David J A
and Sievenpiper, John L",
title="Acceptability of a Web-Based Health App (PortfolioDiet.app) to Translate a Nutrition Therapy for Cardiovascular Disease in High-Risk Adults: Mixed Methods Randomized Ancillary Pilot Study",
journal="JMIR Cardio",
year="2025",
month="Mar",
day="28",
volume="9",
pages="e58124",
keywords="diet; apps; dietary app; Portfolio Diet; dietary portfolio; cholesterol reduction; cardiovascular disease; eHealth; usability; acceptability",
abstract="Background: The Portfolio Diet is a dietary pattern for cardiovascular disease (CVD) risk reduction with 5 key categories including nuts and seeds; plant protein from specific food sources; viscous fiber sources; plant sterols; and plant-derived monounsaturated fatty acid sources. To enhance implementation of the Portfolio Diet, we developed the PortfolioDiet.app, an automated, web-based, multicomponent, patient-facing health app that was developed with psychological theory. Objective: We aimed to evaluate the effect of the PortfolioDiet.app on dietary adherence and its acceptability among adults with a high risk of CVD over 12 weeks. Methods: Potential participants with evidence of atherosclerosis and a minimum of one additional CVD risk factor in an ongoing trial were invited to participate in a remote web-based ancillary study by email. Eligible participants were randomized in a 1:1 ratio using a concealed computer-generated allocation sequence to the PortfolioDiet.app group or a control group for 12 weeks. Adherence to the Portfolio Diet was assessed by weighed 7-day diet records at baseline and 12 weeks using the clinical Portfolio Diet Score, ranging from 0 to 25. Acceptability of the app was evaluated using a multifaceted approach, including usability through the System Usability Scale ranging from 0 to 100, with a score >70 being considered acceptable, and a qualitative analysis of open-ended questions using NVivo 12. Results: In total, 41 participants were invited from the main trial to join the ancillary study by email, of which 15 agreed, and 14 were randomized (8 in the intervention group and 6 in the control group) and completed the ancillary study. At baseline, adherence to the Portfolio Diet was high in both groups with a mean clinical Portfolio Diet Score of 13.2 (SD 3.7; 13.2/25, 53{\%}) and 13.7 (SD 5.8; 13.7/25, 55{\%}) in the app and control groups, respectively. After the 12 weeks, there was a tendency for a mean increase in adherence to the Portfolio Diet by 1.25 (SD 2.8; 1.25/25, 5{\%}) and 0.19 (SD 4.4; 0.19/25, 0.8{\%}) points in the app and control group, respectively, with no difference between groups (P=.62). Participants used the app on average for 18 (SD 14) days per month and rated the app as usable (System Usability Scale of mean 80.9, SD 17.3). Qualitative analyses identified 4 main themes (user engagement, usability, external factors, and added components), which complemented the quantitative data obtained. Conclusions: Although adherence was higher for the PortfolioDiet.app group, no difference in adherence was found between the groups in this small ancillary study. However, this study demonstrates that the PortfolioDiet.app is considered usable by high-risk adults and may reinforce dietitian advice to follow the Portfolio Diet when it is a part of a trial for CVD management. Trial Registration: ClinicalTrials.gov NCT02481466; https://clinicaltrials.gov/study/NCT02481466 ",
issn="2561-1011",
doi="10.2196/58124",
url="https://cardio.jmir.org/2025/1/e58124",
url="https://doi.org/10.2196/58124"
}